Despite the small sample sizes, less unscheduled consultations in insulin-treated patients indicates that this special subgroup, which usually needs closer monitoring, was probably less afraid of hypoglycemia and probably felt more secure with the treatment. The gene discussed is INS; the disease is Hypoglycemia.